Urmila Chemopharma Pvt Ltd - Company Profile

Q: Where is Urmila Chemopharma Pvt Ltd headquartered?

Urmila Chemopharma Pvt Ltd is headquartered at C-63, Ttc Midc, Opp. Toyota Service Centre, Pawane, Navi Mumbai, Maharashtra, 400705.

Q: Who are the current directors of Urmila Chemopharma Pvt Ltd?

The current directors of Urmila Chemopharma Pvt Ltd are Bhalchandra Keshav Rane, Swapnil Digambar Sawant.

It is a pharma private limited company based in Navi Mumbai, Maharashtra, India, established in 1992.

1992 Navi Mumbai, Maharashtra, India Active

Last Updated: December 30, 2025

Access Report

About Urmila Chemopharma Pvt Ltd

Urmila Chemopharma Pvt Ltd, a active private limited company, was established on 05 March 1992 in Navi Mumbai, Maharashtra, India. Engaging in api manufacturers within the real estate sector, it holds CIN: U24110MH1992PTC065735. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.40 M.

It upholds a compliant status. Its leadership includes Bhalchandra Keshav Rane (Director), Swapnil Digambar Sawant (Director). Past directors included Keshav Jairamrao Rane. It holds no open charges and ₹1.80 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C-6/3, Ttc Midc, Opp. Toyota Service Centre, Pawane, Navi Mumbai, Maharashtra, 400705.

Company Details

CIN/LLPIN
U24110MH1992PTC065735
Registration Number
065735
Incorporation Date
05 March 1992
Authorized Capital
₹1.50 M
Paid-Up Capital
₹1.40 M
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.50 M as on 30-12-2025
Paid Up Capital ₹ 1.40 M as on 30-12-2025
Company Age 33 Year, 11 Months
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 1.80 Cr as on 30-12-2025
Revenue Growth **** -11.29% (FY 2023)
Profit Growth **** -10.96% (FY 2023)
Ebitda **** -22.89% (FY 2023)
Net Worth 3.58% (FY 2023)
Total Assets -3.10% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Urmila Chemopharma Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Urmila Chemopharma Pvt Ltd?

Current Directors

Name	Designation	Appointment Date	Status
Bhalchandra Keshav Rane	Director	05 Mar 1992	Current
Swapnil Digambar Sawant	Director	28 Aug 2018	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	02 Jul 2018	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Urmila Chemopharma.

Urmila Chemopharma Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.29% decrease. The company also saw a substantial fall in profitability, with a 10.96% decrease in profit. The company's net worth moved up by a moderate rise of 3.58%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-11.29%

*******

Revenue from Operations

*******

-16.57%

*******

Total Assets

*******

-3.10%

*******

Profit or Loss

*******

-10.96%

*******

Net Worth

*******

3.58%

*******

EBITDA

*******

-22.89%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Urmila Chemopharma?

Unlock access to Urmila Chemopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹18,047,000.00

Charges Breakdown by Lending Institutions

Punjab National Bank : 1.80 Cr

Latest Charge Details

Date	Lender	Amount	Status
27 Dec 2010	Punjab National Bank	₹0.55 M	Satisfied
15 Oct 1998	Punjab National Bank	₹1.75 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Urmila Chemopharma?

Unlock and access historical data on people associated with Urmila Chemopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Urmila Chemopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Urmila Chemopharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Urmila Chemopharma

Recent Activity within the Organization

Annual General Meeting

Progress on Urmila Chemopharma Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
30 Sep 2025
Balance Sheet

Progress on Urmila Chemopharma Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
31 Mar 2025
Charges

Progress on A charge registered on 27 Dec 2010 via Charge ID 10271766 with Punjab National Bank was fully satisfied on 11 Sep 2020. was documented.
11 Sep 2020
Charges

The activity A charge registered on 15 Oct 1998 via Charge ID 90142240 with Punjab National Bank was fully satisfied on 11 Sep 2020. was completed.
11 Sep 2020
Director Appointment

The activity Swapnil Digambar Sawant was appointed as a Director was appointed as a Director on 28 Aug 2018 & has been associated with this company since 7 years 5 months . was completed.
28 Aug 2018
Charges

The activity A charge with Punjab National Bank of Rs. 17.50 M registered on 15 Oct 1998 with Charge ID 90142240 was modified on 08 Jan 2014. was completed.
08 Jan 2014

Explore recent activity and updates - View Recent Activity